Ticker Scorecard - APRE Basics Company: Aprea Therapeutics, Inc. IPO Date: September 30, 2019 Sector: Healthcare Industry: Biotech Market Cap: $21.2M Activated in VL: True Average Daily Range Avg Daily Range: $0.38 | 3.72% Avg Daily Range (30 D): $0.14 | 3.99% Avg Daily Range (90 D): $0.14 | 3.92% Institutional Daily Volume Avg Daily Volume: .03M Avg Daily Volume (30 D): .02M Avg Daily Volume (90 D): .02M Trade Size Avg Trade Size (Sh.): 13 Avg Trade Size (Sh.) (30 D): 155 Avg Trade Size (Sh.) (90 D): 182 Institutional Trades Total Inst.Trades: 119 Avg Inst. Trade: $1.73M Avg Inst. Trade (30 D): $.52M Avg Inst. Trade (90 D): $.52M Avg Inst. Trade Volume: .01M Avg Inst. Trades (Per Day): 1 Market Closing Trades Avg Closing Trade: $2.74M Avg Closing Trade (30 D): $M Avg Closing Trade (90 D): $M Avg Closing Volume: 7.56K     News Jun 21, 2024 @ 12:00 PM Aprea Therapeutics to Host Virtual KOL Event on AP... Source: Aprea Therapeutics Jun 17, 2024 @ 12:30 PM Aprea Therapeutics Announces First Patient Dosed i... Source: Aprea Therapeutics May 28, 2024 @ 12:45 PM Aprea Therapeutics Announces that Safety Review Co... Source: Aprea Therapeutics May 13, 2024 @ 8:01 PM Aprea Therapeutics to Attend the 2024 RBC Capital ... Source: Aprea Therapeutics May 2, 2024 @ 1:15 PM Aprea Therapeutics Announces Appointment of Nadeem... Source: Aprea Therapeutics Financials   TTM Q2 2024 Q1 2024 Basic EPS $-.64 $-.58 $-.67 Diluted EPS $-.64 $-.58 $-.67 Revenue $ .35M $ .56M $ .38M Gross Profit $ $ $ Net Income / Loss $ -3.78M $ -3.47M $ -2.81M Operating Income / Loss $ -4.1M $ -3.85M $ -3.15M Cost of Revenue $ $ $ Net Cash Flow $ -2.47M $ -3.67M $ 10.77M PE Ratio     Splits Feb 13, 2023:   20:1 Dec 27, 2018:   1000:1 Sep 13, 2011:   500:1